Filgrastim (r-metHuG-CSF) in Clinical Practice

Biology of G-CSF, Graham Molineux and T. Michael Dexter; biochemistry and structure of Filgrastim (r-metHuG-CSF), Timothy Osslund and Thomas Boone; Pharmacology of Filgrastim (r-metHuG-CSF), Martha E. Vincent et al; causes, clinical consequences, and treatment of Neutropenia, Thomas Waits and David H. Johnson; use of Filgrastim (r-metHuG-CSF) in severe chronic Neutropenia, David C. Dale et al; Filgrastim (r-metHuG-CSF) in the Chemotherapy setting, Susan Blackwell and Jeffrey Crawford; use of Filgrastim (r-metHuG-CSF) in human immunodeficiency virus infection, Steven A. Miles; the importance of dose in Cancer Chemotherapy and the role of Hematopoietic growth factors, Miguel H. Bronchud; Filgrastim (r-metHuG-CSF) in bone-marrow and peripheral blood cell transplantation, Gary Spitzer et al; use of Filgrastim (r-metHuG-CSF) in peripheral blood progenitor cell support, Rowan Grant Doig and William P. Sheridan; Filgrastim (r-metHuG-CSF) for the treatment of Myelodysplastic Syndromes, Robert S. Negrin and Peter L. Greenberg; use of Filgrastim (r-metHuG-CSF) in acute Myeloid Leukemia, Ryuzo Ohno; use of Filgrastim (r-metHuG-CSF) in infectious disease, Steve Nelson et al; safety profile of Filgrastim (r-metHuG-CSF), Genevieve Decoster et al; economic impact of Filgrastim (r-metHuG-CSF), John A. Glaspy et al; practical aspects of Filgrastim (r-metHuG-CSF) administration, Debra M. Shoemaker and Mary Ruth Pupa; quality of life with Filgrastim (r-metHuG-CSF), Breege Traynor.